Real-time enrollment status for this atrial fibrillation clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 7:14 PM UTC
| NCT Number | NCT06959121 |
| Recruiting Status | Recruiting |
| Condition | Atrial Fibrillation |
| Phase | NA |
| Target Enrollment | 135 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Pulse Biosciences, Inc. |
| Last Updated on CT.gov | September 9, 2026 (Sep 9, 2026) |
As of October 18, 2026: Clinical trial NCT06959121 is currently recruiting participants. This na study for atrial fibrillation is actively seeking new participants at 3 locations across the United States. The study is sponsored by Pulse Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06959121 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06959121 was last updated Sep 9, 2026 (September 9, 2026). HelloStudys verifies this status automatically.